Madrigal Pharmaceuticals IncNASDAQ:MDGL
No Matches were found for
- LAST PRICE331.3200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots316.1800/ 2
- Ask / Lots526.7900/ 1
- Open / Previous Close--- / 331.3200
- Day Range---
- 52 Week Range
- Volume10
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Select an index
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MDGL |
|---|---|---|
| 09:32 ET | 12246 | 317.81 |
| 09:33 ET | 7883 | 319.1989 |
| 09:35 ET | 6179 | 317.965 |
| 09:37 ET | 7657 | 317.42 |
| 09:39 ET | 6785 | 316.475 |
| 09:42 ET | 2563 | 312.63 |
| 09:44 ET | 1050 | 313.1401 |
| 09:46 ET | 1225 | 314.005 |
| 09:48 ET | 4974 | 312.45 |
| 09:50 ET | 1367 | 312.48 |
| 09:51 ET | 300 | 312.56 |
| 09:53 ET | 100 | 312.83 |
| 09:55 ET | 3188 | 315 |
| 09:57 ET | 1218 | 316.165 |
| 10:00 ET | 778 | 318 |
| 10:02 ET | 1721 | 319.93 |
| 10:04 ET | 4681 | 319.713762 |
| 10:06 ET | 2199 | 319 |
| 10:08 ET | 725 | 321.5 |
| 10:09 ET | 3152 | 322.63 |
| 10:11 ET | 224 | 321.49 |
| 10:13 ET | 20852 | 326.77 |
| 10:15 ET | 11531 | 325.935 |
| 10:18 ET | 1202 | 325.02 |
| 10:20 ET | 3437 | 326.87 |
| 10:22 ET | 3139 | 328.5 |
| 10:24 ET | 3200 | 326.55 |
| 10:26 ET | 4600 | 329.98 |
| 10:27 ET | 7788 | 328.46 |
| 10:29 ET | 556 | 328.59 |
| 10:31 ET | 21072 | 320.65 |
| 10:33 ET | 10400 | 321.115 |
| 10:36 ET | 4547 | 321.69 |
| 10:38 ET | 1700 | 323.48 |
| 10:40 ET | 3391 | 320.595 |
| 10:42 ET | 931 | 321.78 |
| 10:44 ET | 400 | 323.01 |
| 10:45 ET | 1123 | 324.785 |
| 10:47 ET | 1948 | 323.01 |
| 10:49 ET | 702 | 325.82 |
| 10:51 ET | 1327 | 326.96 |
| 10:54 ET | 1404 | 327.535 |
| 10:56 ET | 1097 | 328.28 |
| 10:58 ET | 100 | 328.94 |
| 11:00 ET | 2175 | 327 |
| 11:02 ET | 400 | 326.18554 |
| 11:05 ET | 1221 | 326.65 |
| 11:07 ET | 3488 | 326.575 |
| 11:09 ET | 400 | 327.47 |
| 11:12 ET | 400 | 327.51 |
| 11:14 ET | 400 | 328.66 |
| 11:16 ET | 100 | 329 |
| 11:18 ET | 1187 | 329.68 |
| 11:20 ET | 1727 | 328.1 |
| 11:21 ET | 709 | 328.31 |
| 11:23 ET | 750 | 328 |
| 11:25 ET | 349 | 328.37 |
| 11:27 ET | 2098 | 329.75 |
| 11:30 ET | 3648 | 330 |
| 11:32 ET | 4187 | 329.31 |
| 11:34 ET | 4000 | 331.19 |
| 11:36 ET | 7400 | 330.58 |
| 11:38 ET | 2297 | 331.1625 |
| 11:39 ET | 1367 | 331.05 |
| 11:41 ET | 3201 | 331.57 |
| 11:43 ET | 1784 | 330.0936 |
| 11:45 ET | 300 | 329.75 |
| 11:48 ET | 2626 | 329.7163 |
| 11:50 ET | 669 | 330 |
| 11:52 ET | 1000 | 331.36 |
| 11:54 ET | 2695 | 330.6 |
| 11:56 ET | 2600 | 329.98 |
| 11:57 ET | 1880 | 329.5 |
| 11:59 ET | 1952 | 330.95 |
| 12:01 ET | 300 | 330.8384 |
| 12:03 ET | 312 | 330.91 |
| 12:06 ET | 2100 | 329.93 |
| 12:08 ET | 957 | 330.88 |
| 12:10 ET | 16527 | 328.58 |
| 12:12 ET | 600 | 329.17 |
| 12:14 ET | 1356 | 330.95 |
| 12:15 ET | 225 | 330.61 |
| 12:17 ET | 5170 | 328.125 |
| 12:19 ET | 2767 | 328.885 |
| 12:21 ET | 2360 | 329.65 |
| 12:24 ET | 1900 | 329.635 |
| 12:26 ET | 600 | 330 |
| 12:28 ET | 1600 | 330.03 |
| 12:30 ET | 3349 | 329.96 |
| 12:32 ET | 1893 | 330.04 |
| 12:33 ET | 494 | 330.3 |
| 12:35 ET | 1840 | 329.5 |
| 12:37 ET | 1900 | 329.48 |
| 12:39 ET | 139 | 330.4769 |
| 12:42 ET | 400 | 329.9074 |
| 12:44 ET | 700 | 330 |
| 12:46 ET | 1575 | 330.285 |
| 12:48 ET | 750 | 331.5471 |
| 12:50 ET | 3253 | 333 |
| 12:51 ET | 300 | 333.14 |
| 12:55 ET | 651 | 332.5461 |
| 12:57 ET | 100 | 333.01 |
| 01:00 ET | 2605 | 334.2 |
| 01:02 ET | 1658 | 334.995 |
| 01:04 ET | 15369 | 335.55 |
| 01:06 ET | 737 | 335.95 |
| 01:08 ET | 3197 | 336 |
| 01:09 ET | 260 | 336.055 |
| 01:11 ET | 2110 | 336.4957 |
| 01:13 ET | 2774 | 336.035 |
| 01:15 ET | 233 | 336 |
| 01:18 ET | 3910 | 335.21 |
| 01:20 ET | 1200 | 336.16 |
| 01:24 ET | 732 | 336.6 |
| 01:26 ET | 350 | 335.96 |
| 01:27 ET | 1099 | 335.735 |
| 01:29 ET | 300 | 335.585 |
| 01:31 ET | 359 | 335.765 |
| 01:33 ET | 415 | 335.43 |
| 01:36 ET | 2722 | 335.64 |
| 01:38 ET | 3930 | 332.8481 |
| 01:40 ET | 200 | 332.2401 |
| 01:42 ET | 2381 | 332.465 |
| 01:44 ET | 1370 | 333.4599 |
| 01:45 ET | 600 | 333.47 |
| 01:47 ET | 758 | 334.82 |
| 01:49 ET | 1200 | 335.135 |
| 01:51 ET | 1957 | 334.83 |
| 01:54 ET | 6107 | 334.875 |
| 01:56 ET | 439 | 334.6 |
| 01:58 ET | 1760 | 333.9858 |
| 02:00 ET | 600 | 332.8 |
| 02:02 ET | 1202 | 332.56 |
| 02:03 ET | 1766 | 332.68 |
| 02:09 ET | 200 | 332.685 |
| 02:12 ET | 100 | 332.22 |
| 02:14 ET | 2325 | 331.91 |
| 02:16 ET | 100 | 331.725 |
| 02:18 ET | 260 | 331.12 |
| 02:20 ET | 900 | 331.24 |
| 02:21 ET | 518 | 331.76 |
| 02:23 ET | 352 | 331.555 |
| 02:25 ET | 2085 | 330.171 |
| 02:27 ET | 850 | 330.26 |
| 02:30 ET | 1647 | 330.3404 |
| 02:32 ET | 1415 | 330 |
| 02:34 ET | 300 | 331.07 |
| 02:36 ET | 300 | 332.5 |
| 02:38 ET | 303 | 332.49 |
| 02:39 ET | 1370 | 332.28 |
| 02:41 ET | 2379 | 333.325 |
| 02:43 ET | 1997 | 332.425 |
| 02:48 ET | 100 | 331.85 |
| 02:50 ET | 900 | 331.55 |
| 02:52 ET | 900 | 331.67 |
| 02:54 ET | 1394 | 331.625 |
| 02:56 ET | 1930 | 333.175 |
| 02:57 ET | 7994 | 334.115 |
| 02:59 ET | 400 | 334.365 |
| 03:01 ET | 8393 | 333.945 |
| 03:03 ET | 11008 | 334.045 |
| 03:06 ET | 5473 | 334.97 |
| 03:08 ET | 7944 | 335.24 |
| 03:10 ET | 1100 | 335.26 |
| 03:12 ET | 2482 | 335.07 |
| 03:14 ET | 700 | 335.25 |
| 03:15 ET | 431 | 335.01 |
| 03:17 ET | 351 | 335.7799 |
| 03:19 ET | 4692 | 334.8 |
| 03:21 ET | 2480 | 334.13 |
| 03:24 ET | 873 | 335.61 |
| 03:26 ET | 2134 | 336.23 |
| 03:28 ET | 1751 | 336.75 |
| 03:30 ET | 3892 | 336.69 |
| 03:32 ET | 2286 | 337.05 |
| 03:33 ET | 1800 | 336.45 |
| 03:35 ET | 2845 | 336.86 |
| 03:37 ET | 9074 | 335.16 |
| 03:39 ET | 2068 | 334.78 |
| 03:42 ET | 1550 | 335.175 |
| 03:44 ET | 684 | 335.87 |
| 03:46 ET | 3873 | 335.63 |
| 03:48 ET | 6680 | 333.68 |
| 03:50 ET | 2574 | 333.52 |
| 03:51 ET | 2343 | 334.21 |
| 03:53 ET | 6648 | 332.84 |
| 03:55 ET | 7460 | 332.755 |
| 03:57 ET | 7519 | 331.1745 |
| 04:00 ET | 68544 | 331.32 |
Nov 1, 2024
DJ Madrigal Pharmaceuticals Is Maintained at Buy by UBS, from 2:37PM ET on Friday Nov 01, 2024 by Dow Jones
2:37PM ET on Friday Nov 01, 2024 by Dow Jones
Oct 31, 2024
Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates, from 7:01AM ET on Thursday Oct 31, 2024 by Dow Jones
7:01AM ET on Thursday Oct 31, 2024 by Dow Jones*DJ Madrigal Pharmaceuticals 3Q Loss/Shr $4.92 >MDGL, from 7:01AM ET on Thursday Oct 31, 2024 by Dow Jones
7:01AM ET on Thursday Oct 31, 2024 by Dow Jones
Oct 30, 2024
Madrigal Pharmaceuticals to Present Multiple Rezdiffra(TM) (resmetirom) Abstracts in NASH/MASH at the AASLD Liver Meeting(R), from 8:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
8:00AM ET on Wednesday Oct 30, 2024 by Dow Jones
Oct 23, 2024
DJ Madrigal Pharmaceuticals Is Maintained at Outperform by Oppenheimer, from 8:34AM ET on Wednesday Oct 23, 2024 by Dow Jones
8:34AM ET on Wednesday Oct 23, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Madrigal Pharmaceuticals Inc | 7.2B | -13.2x | --- |
Viking Therapeutics Inc | 7.0B | -67.4x | --- |
Cytokinetics Inc | 6.1B | -9.6x | --- |
Nuvalent Inc | 5.8B | -32.2x | --- |
Avidity Biosciences Inc | 5.3B | -15.2x | --- |
Crinetics Pharmaceuticals Inc | 5.1B | -15.1x | --- |
Company Information
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.
Contact Information
- Headquarters
- 200 Barr Harbor Dr Ste 400WEST CONSHOHOCKEN, PA, United States 19428-2978
- Phone
- 404-380-9263
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Julian Baker
- President, Chief Executive Officer, Director
- Bill Sibold
- Chief Financial Officer, Senior Vice President
- Mardi Dier
- President of Research and Development, Chief Medical Officer, Director
- Rebecca Taub
- Senior Vice President - Clinical Development
- Michael Charlton
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.2B |
|---|---|
Revenue (TTM) | $76.8M |
Shares Outstanding | 21.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.50 |
EPS | $-25.07 |
Book Value | $20.39 |
P/E Ratio | -13.2x |
Price/Sales (TTM) | 94.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -713.49% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
